Larson Financial Group’s Dr. Reddy's Laboratories RDY Stock Holding History

Larson Financial Group’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$46.4K	Buy	3,200 +320	+11%	+$4.32K	﹤0.01%	1554
2026 Q1	$39.9K	Sell	2,880 -293	-9%	-$4.08K	﹤0.01%	1469
2025 Q4	$44.5K	Buy	3,173 +1,425	+82%	+$20K	﹤0.01%	1289
2025 Q3	$24.4K	Buy	1,748 +205	+13%	+$2.95K	﹤0.01%	1525
2025 Q2	$23.2K	Buy	1,543 +810	+111%	+$11.6K	﹤0.01%	1417
2025 Q1	$9.66K	Hold	733	–	–	﹤0.01%	1649
2024 Q4	$11.6K	Sell	733 -2	-0.3%	-$30	﹤0.01%	1432
2024 Q3	$11.6K	Hold	735	–	–	﹤0.01%	1423
2024 Q2	$11.2K	Hold	735	–	–	﹤0.01%	1226
2024 Q1	$10.8K	Hold	735	–	–	﹤0.01%	1024
2023 Q4	$10.2K	Hold	735	–	–	﹤0.01%	1011
2023 Q3	$9.8K	Buy	735 +5	+0.7%	+$68	﹤0.01%	1002
2023 Q2	$9.2K	Hold	730	–	–	﹤0.01%	961
2023 Q1	$8.29K	Hold	730	–	–	﹤0.01%	980
2022 Q4	$7.54K	Hold	730	–	–	﹤0.01%	942
2022 Q3	$8K	Buy	730 +5	+0.7%	+$53	﹤0.01%	852
2022 Q2	$8K	Hold	725	–	–	﹤0.01%	786
2022 Q1	$8K	Hold	725	–	–	﹤0.01%	713
2021 Q4	$9K	Hold	725	–	–	﹤0.01%	710
2021 Q3	$9K	Buy	725 +5	+0.7%	+$67	﹤0.01%	616
2021 Q2	$11K	Hold	720	–	–	﹤0.01%	542
2021 Q1	$9K	Hold	720	–	–	﹤0.01%	570
2020 Q4	$10K	Hold	720	–	–	﹤0.01%	497
2020 Q3	$10K	Hold	720	–	–	﹤0.01%	437
2020 Q2	$8K	Hold	720	–	–	﹤0.01%	430
2020 Q1	$6K	Hold	720	–	–	﹤0.01%	355
2019 Q4	$6K	Hold	720	–	–	﹤0.01%	354
2019 Q3	$5K	Buy	720 +5	+0.7%	+$37	﹤0.01%	370
2019 Q2	$5K	Hold	715	–	–	﹤0.01%	317
2019 Q1	$6K	Hold	715	–	–	﹤0.01%	276
2018 Q4	$5K	Buy	+715	New	+$5.03K	﹤0.01%	278

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Larson Financial Group's RDY Position: Q2 2026 in Review

Larson Financial Group increased its Dr. Reddy's Laboratories (RDY) stake by 11% in Q2 2026, buying an estimated $4.32K and bringing the position to 3,200 shares worth $46.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1554.

Larson Financial Group first reported a position in RDY in Q4 2018 and has held it in 31 quarters since. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

Larson Financial Group held 3,200 shares of Dr. Reddy's Laboratories worth $46.4K as of Q2 2026.
Larson Financial Group bought 320 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $4.32K.
Dr. Reddy's Laboratories made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #1554 holding.
Larson Financial Group first reported a position in Dr. Reddy's Laboratories in Q4 2018 and has held it in 31 quarters since.
238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.